Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery.
Livi L, Stefanacci M, Scoccianti S, Dicosmo D, Borghesi S, Nosi F, Simontacchi G, Mangoni M, Paiar F, Ponticelli P, Nori J, Chiavacci A, Biti GP. Livi L, et al. Among authors: stefanacci m. Clin Oncol (R Coll Radiol). 2007 Mar;19(2):120-4. doi: 10.1016/j.clon.2006.11.006. Clin Oncol (R Coll Radiol). 2007. PMID: 17355107
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
Pegurri L, Buglione M, Girelli G, Guarnieri A, Meattini I, Ricardi U, Mangoni M, Gabriele P, Bellavita R, Krengli M, Bonetta A, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Gatta R, De Bari B, Magrini SM. Pegurri L, et al. Among authors: stefanacci m. Tumori. 2014 Jan-Feb;100(1):31-7. doi: 10.1700/1430.15812. Tumori. 2014. PMID: 24675488
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).
Ingrosso G, Ponti E, Francolini G, Caini S, Fondelli S, Santini R, Valeriani M, Rago L, Duroni G, Bruni A, Augurio A, Tramacere F, Trippa F, Russo D, Bottero M, Tamburo M, Parisi S, Borghesi S, Lancia A, Gomellini S, Scoccianti S, Stefanacci M, Vullo G, Statuto T, Miranda G, Santo B, Di Marzo A, Bellavita R, Vinciguerra A, Livi L, Aristei C, Bertini N, Orsatti C, Detti B. Ingrosso G, et al. Among authors: stefanacci m. Radiol Med. 2024 Apr;129(4):643-652. doi: 10.1007/s11547-024-01782-2. Epub 2024 Feb 19. Radiol Med. 2024. PMID: 38369638 Free PMC article.
Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.
De Bari B, Vallati M, Gatta R, Simeone C, Girelli G, Ricardi U, Meattini I, Gabriele P, Bellavita R, Krengli M, Cafaro I, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Pasinetti N, Buglione M, Magrini SM. De Bari B, et al. Among authors: stefanacci m. Cancer Invest. 2015 Jul;33(6):232-40. doi: 10.3109/07357907.2015.1024317. Epub 2015 May 7. Cancer Invest. 2015. PMID: 25950849
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Buglione M, et al. Among authors: stefanacci m. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):462-472. doi: 10.1016/j.ijrobp.2016.10.011. Epub 2016 Oct 20. Int J Radiat Oncol Biol Phys. 2017. PMID: 27986347 Clinical Trial.
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions.
Fellin G, Mirri MA, Santoro L, Jereczek-Fossa BA, Divan C, Mussari S, Ziglio F, La Face B, Barbera F, Buglione M, Bandera L, Ghedi B, Di Muzio NG, Losa A, Mangili P, Nava L, Chiarlone R, Ciscognetti N, Gastaldi E, Cattani F, Spoto R, Vavassori A, Giglioli FR, Guarneri A, Cerboneschi V, Mignogna M, Paoluzzi M, Ravaglia V, Chiumento C, Clemente S, Fusco V, Santini R, Stefanacci M, Mangiacotti FP, Martini M, Palloni T, Schinaia G, Lazzari G, Silvano G, Magrini S, Ricardi U, Santoni R, Orecchia R. Fellin G, et al. Among authors: stefanacci m. Br J Radiol. 2016 Sep;89(1065):20150981. doi: 10.1259/bjr.20150981. Epub 2016 Jul 7. Br J Radiol. 2016. PMID: 27384381 Free PMC article.
Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy.
Scoccianti S, Delli Paoli C, Infantino M, Paoletti L, Caini S, Meacci F, Russo S, Esposito M, Fondelli S, Grilli Leonulli B, Grossi V, Barca R, Alpi P, Furlan F, Perna M, Pino MS, Martella F, Manfredi M, Stefanacci M, Bassetti A, Casprini P, Fioretto L. Scoccianti S, et al. Among authors: stefanacci m. Int Immunopharmacol. 2023 Sep;122:110460. doi: 10.1016/j.intimp.2023.110460. Epub 2023 Jun 29. Int Immunopharmacol. 2023. PMID: 37392566
Departmental libraries: why do they exist?
Stefanacci MA, Wood MS, Huff LD. Stefanacci MA, et al. Bull Med Libr Assoc. 1977 Oct;65(4):433-7. Bull Med Libr Assoc. 1977. PMID: 901953 Free PMC article.